Profiel
Pavel Hamet is the founder of Prognomix, Inc. (founded in 2005) and currently holds the position of President, Co-Chief Executive Officer & Director.
He is also currently a Director at Bellus Health (Innodia), Inc., Canadian Institutes of Health Research, Medpharmgene, Inc., and a Professor at the University of Montréal.
Dr. Hamet previously served as Chairman at Canada Foundation for Innovation, Director at AGC Biologics SpA, Director at BioCapital Investment Advisors, Inc. (from 2003 to 2005), Director at Société de développement Angus, and President at Canadian Hypertension Society.
He obtained a doctorate degree from McGill University in 1972 and another doctorate degree from the University of Charles in 1967.
Actieve functies van Pavel Hamet
Bedrijven | Functie | Begin |
---|---|---|
Bellus Health (Innodia), Inc.
Bellus Health (Innodia), Inc. Pharmaceuticals: MajorHealth Technology Bellus Health (Innodia), Inc. manufactures biopharmaceutical products for the treatment and prevention of amyloidosis, metabolic syndrome, and diabetics related diseases. The company was founded in 2002 and is headquartered in Laval, Canada. | Director/Board Member | - |
Prognomix, Inc.
Prognomix, Inc. Pharmaceuticals: GenericHealth Technology Prognomix, Inc. develops market molecular diagnostic kits for testing of diabetes complications. Its products include PGX IR01, PGx GR01, PGx CD01 and PGx IR02. The firm focuses on discovery and clinical application of genomic signatures predictive of susceptibility to diseases, their complications and individual therapeutic responsiveness. The company was founded by Johanne Tremblay and Pavel Hamet in 2005 and is headquartered in Montreal, Canada. | Founder | 01-01-2005 |
Canadian Institutes of Health Research
Canadian Institutes of Health Research Miscellaneous Commercial ServicesCommercial Services The Canadian Institutes of Health Research is the federal health research financing organization in Canada. The non-profit company is based in Ottawa, Canada. The organization's main focus is to fund health research projects across the country. | Director/Board Member | 02-06-2010 |
University of Montréal | Corporate Officer/Principal | - |
Société Francophone Du Diabete | Director/Board Member | 01-01-2010 |
Medpharmgene, Inc.
Medpharmgene, Inc. Miscellaneous Commercial ServicesCommercial Services Medpharmgene, Inc. provides commercial physical research services. The private company is based in Montréal, Canada and was founded in 2001. | Director/Board Member | - |
Eerdere bekende functies van Pavel Hamet
Bedrijven | Functie | Einde |
---|---|---|
BioCapital Investment Advisors, Inc.
BioCapital Investment Advisors, Inc. Investment ManagersFinance Montréal-based BioCapital Investment Advisors, Inc. manages the BioCapital health technology mutual fund family. | Director/Board Member | 31-12-2005 |
Société de développement Angus
Société de développement Angus Real Estate DevelopmentFinance Société de développement Angus engages in real estate developments. It specializes in concept development and planning, legal and financial engineering services, acquisition of land and buildings, and marketing, leasing and sales of developed spaces. The company was founded by Christian Yaccarini in 1995 and is headquartered in Montreal, Canada. | Director/Board Member | - |
Canadian Hypertension Society | President | - |
░░░░░░ ░░░░░░░░░░ ░░░ ░░░░░░░░░░ | ░░░░░░░░ | - |
░░░░░░ ░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Opleiding van Pavel Hamet
McGill University | Doctorate Degree |
University of Charles | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 10 |
---|---|
AGC Biologics SpA
AGC Biologics SpA Pharmaceuticals: MajorHealth Technology AGC Biologics SpA engages in the research, development, manufacturing, and clinical validation of cell and gene therapies for the treatment of cancer and rare diseases. Its approach is based on finding drugs that target the reduction of tumor mass in the acute stage, as well as on the provision of selective therapies to eliminate the residual disease. It also conducts cell and gene therapy projects in collaboration with third parties, offering resources and expertise covering preclinical to Phase III trial activities. The company was founded by Claudio Bordignon on July 11, 1996 and is headquartered in Milan, Italy. | Health Technology |
BioCapital Investment Advisors, Inc.
BioCapital Investment Advisors, Inc. Investment ManagersFinance Montréal-based BioCapital Investment Advisors, Inc. manages the BioCapital health technology mutual fund family. | Finance |
Bellus Health (Innodia), Inc.
Bellus Health (Innodia), Inc. Pharmaceuticals: MajorHealth Technology Bellus Health (Innodia), Inc. manufactures biopharmaceutical products for the treatment and prevention of amyloidosis, metabolic syndrome, and diabetics related diseases. The company was founded in 2002 and is headquartered in Laval, Canada. | Health Technology |
Prognomix, Inc.
Prognomix, Inc. Pharmaceuticals: GenericHealth Technology Prognomix, Inc. develops market molecular diagnostic kits for testing of diabetes complications. Its products include PGX IR01, PGx GR01, PGx CD01 and PGx IR02. The firm focuses on discovery and clinical application of genomic signatures predictive of susceptibility to diseases, their complications and individual therapeutic responsiveness. The company was founded by Johanne Tremblay and Pavel Hamet in 2005 and is headquartered in Montreal, Canada. | Health Technology |
Canada Foundation For Innovation | Miscellaneous |
Canadian Institutes of Health Research
Canadian Institutes of Health Research Miscellaneous Commercial ServicesCommercial Services The Canadian Institutes of Health Research is the federal health research financing organization in Canada. The non-profit company is based in Ottawa, Canada. The organization's main focus is to fund health research projects across the country. | Commercial Services |
Canadian Hypertension Society | |
Medpharmgene, Inc.
Medpharmgene, Inc. Miscellaneous Commercial ServicesCommercial Services Medpharmgene, Inc. provides commercial physical research services. The private company is based in Montréal, Canada and was founded in 2001. | Commercial Services |
Société de développement Angus
Société de développement Angus Real Estate DevelopmentFinance Société de développement Angus engages in real estate developments. It specializes in concept development and planning, legal and financial engineering services, acquisition of land and buildings, and marketing, leasing and sales of developed spaces. The company was founded by Christian Yaccarini in 1995 and is headquartered in Montreal, Canada. | Finance |
Société Francophone Du Diabete |